Professional services

RISK MANAGEMENT

Professional services

Helping you protect your business and your reputation.

The world moves fast, and so do we.

Lockton has earned a reputation as a leading risk management and employee benefits advisor to professional services firms like yours. The expertise and experience of the Lockton team will help you protect your business and your reputation when you face claims by dissatisfied clients alleging neglect, errors and omissions.

The world moves fast, and so do we. Some might call it “Lockton speed.” But equally important as being quick on our feet, agile and flexible is our ability to pause, consider, and move deliberately forward. The conveyor-belt mentality does nothing for us – or you.

We make it our business to chart the course, working as an extension of your team. Together, we will address the many challenges facing your unique business, including the ever-changing regulatory climate, litigious proclivities, cyber threats, technology advancements, to name a few.

Formula for success

Lockton’s business model provides you with a formula for success. Whatever your profession, we deliver insurance and risk management solutions that offer the best possible value and flexibility to meet the changing needs of your business.  

Our business is focused on helping make your business better.  

As the world’s largest privately held, independent insurance broker, we answer to no one but our clients. This frees us to challenge the norms, to push the envelope, to think outside the box. And this is where and how some of the best, most custom-made solutions are found. Creative and effective, bold and informed, extraordinarily focused and purposefully unconventional.  



Business Woman smiling talking to colleague

Latest news & insights

The United Kingdom is introducing a statutory entitlement to neonatal care leave and pay for parents of babies born on or after 6 April 2025, who require neonatal care after birth.The UK implements neonatal care leave and pay entitlement

GLP-1 Indications continue to expand: Potential approvals expected through 2026

Expanding GLP-1 drug approvals through 2026, including Wegovy’s FDA approval for MASH and anticipated indications for Alzheimer’s, chronic weight management, heart failure, and more.Expanding GLP-1 drug approvals through 2026, including Wegovy’s FDA approval for MASH and anticipated indications for Alzheimer’s, chronic weight management, heart failure, and more.

New Lockton webcast series addresses the latest changes to leave law compliance

New Lockton webcast series addresses the latest changes to leave law complianceNew Lockton webcast series addresses the latest changes to leave law compliance

Amidst continuous change, upcoming ERISA compliance webcasts keep employers in the know

Lockton offers a regular cadence of free webcasts, in which our compliance experts weigh in on a range of pressing issues and changes under the Employee Retirement Income Security Act (ERISA).Lockton offers a regular cadence of free webcasts, in which our compliance experts weigh in on a range of pressing issues and changes under the Employee Retirement Income Security Act (ERISA).
View All news and insights